Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Benchmarks help you measure performance. This intro explains which indices serve as benchmarks and how investors use them to compare risk and return.
20,611 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A single quantum computing stock could reshape your portfolio like Palantir did for AI software. This guide breaks do...
Clark Howard weighs in on helping a family member build credit without jeopardizing your own score, after a May 11, 2...
VanEck's NLR ETF blends uranium miners, enrichers and reactor operators, trading at 0.61%, as investors seek a balanc...
A high-stakes power struggle within the Labour Party erupted this week as Health Secretary Wes Streeting resigned, sp...
A cross-party group of UK lawmakers is probing how banks treat crypto businesses. The inquiry aims to uncover barrier...
Jefferies boosts Palo Alto Networks price target to $265 with a Buy rating as AI-driven threats compress attack timel...
Age-verification efforts aimed at safeguarding minors are sparking a broader push toward universal online IDs, with p...
The 2026 Hedge Fund Alternative Manager Forum brought together leaders to share how AI, data, and differentiated stra...
An unexpected move by Etsy’s board member sparked questions about insider trading activity. This article breaks down ...
Investors are watching Bullish (BLSH) as Q1 2026 results set the tone for the year. This guide breaks down the earnin...
Celebrity dating rumors can ping our finances in surprising ways. This piece breaks down practical money skills you c...